Harrow, Inc. Depreciation
Harrow, Inc. (HROW) reported Depreciation of $351.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2024-11-14
- Harrow, Inc. depreciation for the quarter ending 2024-09-30 was $351.00K, a 21.03% increase year-over-year.
- Harrow, Inc. depreciation for the quarter ending 2024-06-30 was $301.00K, a 32.02% increase year-over-year.
- Harrow, Inc. depreciation for the quarter ending 2023-09-30 was $290.00K, a 69.59% increase year-over-year.
- Harrow, Inc. depreciation for the quarter ending 2023-06-30 was $228.00K, a 40.16% decline year-over-year.
- Harrow, Inc. depreciation for fiscal 2017 was $1.40M, a 32.80% increase from fiscal 2016.
- Harrow, Inc. depreciation for fiscal 2016 was $1.05M, a 313.73% increase from fiscal 2015.
- Harrow, Inc. depreciation for fiscal 2015 was $255.00K, a 589.19% increase from fiscal 2014.
- Harrow, Inc. depreciation for fiscal 2014 was $37.00K, a 553.83% increase from fiscal 2013.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed | Depreciation 155 month | Depreciation 158 month | Depreciation 161 month | Depreciation 164 month | Depreciation 167 month | Depreciation 170 month | Depreciation 173 month | Depreciation 176 month | Depreciation 182 month | Depreciation 185 month | Depreciation 188 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | $351.00K 10-Q · filed 2024-11-14 | $652.00K derived: sum of 2 quarters · filed 2024-11-14 | $948.00K 10-Q · filed 2024-11-14 | |||||||||||||
| 2024-06-30 | $301.00K 10-Q · filed 2024-08-07 | $597.00K 10-Q · filed 2024-08-07 | ||||||||||||||
| 2023-09-30 | $290.00K 10-Q · filed 2024-11-14 | $518.00K derived: sum of 2 quarters · filed 2024-11-14 | $743.00K 10-Q · filed 2024-11-14 | |||||||||||||
| 2023-06-30 | $228.00K 10-Q · filed 2024-08-07 | $453.00K 10-Q · filed 2024-08-07 | ||||||||||||||
| 2023-03-31 | $225.00K 10-Q · filed 2023-05-11 | |||||||||||||||
| 2022-09-30 | $171.00K 10-Q · filed 2023-11-13 | $552.00K derived: sum of 2 quarters · filed 2023-11-13 | $928.00K 10-Q · filed 2023-11-13 | |||||||||||||
| 2022-06-30 | $381.00K 10-Q · filed 2023-08-09 | $757.00K 10-Q · filed 2023-08-09 | ||||||||||||||
| 2022-03-31 | $376.00K 10-Q · filed 2023-05-11 | |||||||||||||||
| 2021-09-30 | $410.00K 10-Q · filed 2022-11-14 | $771.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.20M 10-Q · filed 2022-11-14 | |||||||||||||
| 2021-06-30 | $361.00K 10-Q · filed 2022-08-09 | $797.00K 10-Q · filed 2022-08-09 | ||||||||||||||
| 2021-03-31 | $436.00K 10-Q · filed 2022-05-05 | |||||||||||||||
| 2019-09-30 | $397.00K 10-Q · filed 2019-11-13 | $1.36M 10-Q · filed 2019-11-13 | ||||||||||||||
| 2018-09-30 | $423.00K 10-Q · filed 2018-11-13 | $824.00K derived: sum of 2 quarters · filed 2018-11-13 | $1.22M 10-Q · filed 2018-11-13 | |||||||||||||
| 2018-06-30 | $401.00K 10-Q · filed 2018-08-06 | $800.00K 10-Q · filed 2018-08-06 | ||||||||||||||
| 2018-03-31 | $399.00K 10-Q · filed 2018-05-15 | |||||||||||||||
| 2017-12-31 | $1.40M 10-K · filed 2018-03-08 | |||||||||||||||
| 2016-12-31 | $1.05M 10-K · filed 2018-03-08 | |||||||||||||||
| 2015-12-31 | $255.00K 10-K · filed 2017-03-21 | |||||||||||||||
| 2014-12-31 | $17.45K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | $26.59K derived: sum of 2 quarters · filed 2016-03-23 | $34.44K derived: sum of 3 quarters · filed 2016-03-23 | $37.00K 10-K · filed 2016-03-23 | $37.34K 10-K · filed 2015-03-12 | |||||||||||
| 2014-09-30 | $9.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $16.99K derived: sum of 2 quarters · filed 2014-11-12 | $19.55K 10-Q · filed 2014-11-12 | $21.72K derived: sum of 4 quarters · filed 2015-03-12 | ||||||||||||
| 2014-06-30 | $7.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | $10.41K 10-Q · filed 2014-08-13 | $12.59K derived: sum of 3 quarters · filed 2015-03-12 | $14.00K derived: sum of 4 quarters · filed 2015-03-12 | ||||||||||||
| 2014-03-31 | $2.56K 10-Q · filed 2014-05-15 | $4.73K derived: sum of 2 quarters · filed 2015-03-12 | $6.14K derived: sum of 3 quarters · filed 2015-03-12 | $7.32K derived: sum of 4 quarters · filed 2015-03-12 | $14.31K 10-Q · filed 2014-05-15 | |||||||||||
| 2013-12-31 | $2.18K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $3.59K derived: sum of 2 quarters · filed 2015-03-12 | $4.76K derived: sum of 3 quarters · filed 2015-03-12 | $5.66K 10-K · filed 2015-03-12 | $11.76K 10-K · filed 2014-03-28 | |||||||||||
| 2013-09-30 | $1.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $2.58K derived: sum of 2 quarters · filed 2014-11-12 | $3.48K 10-Q · filed 2014-11-12 | $4.33K derived: sum of 4 quarters · filed 2014-11-12 | $9.58K 10-Q · filed 2013-11-06 | |||||||||||
| 2013-06-30 | $1.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | $2.07K 10-Q · filed 2014-08-13 | $2.93K derived: sum of 3 quarters · filed 2014-08-13 | $3.77K derived: sum of 4 quarters · filed 2014-08-13 | $8.17K 10-Q · filed 2013-08-14 | |||||||||||
| 2013-03-31 | $899.00 10-Q · filed 2014-05-15 | $1.75K derived: sum of 2 quarters · filed 2014-05-15 | $2.60K derived: sum of 3 quarters · filed 2014-05-15 | $3.44K derived: sum of 4 quarters · filed 2014-05-15 | $7.00K 10-Q · filed 2013-05-08 | |||||||||||
| 2012-12-31 | $854.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $1.70K derived: sum of 2 quarters · filed 2014-03-28 | $2.54K derived: sum of 3 quarters · filed 2014-03-28 | $2.94K 10-K · filed 2014-03-28 | $6.10K 10-K · filed 2013-03-18 | |||||||||||
| 2012-09-30 | $843.00 10-Q · filed 2012-11-14 | $1.69K derived: sum of 2 quarters · filed 2012-11-14 | $2.09K 10-Q · filed 2013-11-06 | $2.09K derived: sum of 4 quarters · filed 2013-05-08 | $5.24K 10-Q · filed 2012-11-14 | |||||||||||
| 2012-06-30 | $843.00 10-Q · filed 2012-08-14 | $1.25K 10-Q · filed 2013-08-14 | $1.25K derived: sum of 3 quarters · filed 2013-05-08 | $1.25K derived: sum of 4 quarters · filed 2013-05-08 | $4.40K 10-Q · filed 2012-08-14 | |||||||||||
| 2012-03-31 | $404.00 10-Q · filed 2013-05-08 | $404.00 derived: sum of 2 quarters · filed 2013-05-08 | $404.00 derived: sum of 3 quarters · filed 2013-05-08 | $478.00 derived: sum of 4 quarters · filed 2013-05-08 | $3.56K 10-Q · filed 2012-05-10 | |||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $0.00 derived: sum of 2 quarters · filed 2013-03-18 | $74.00 derived: sum of 3 quarters · filed 2013-03-18 | $338.00 10-K · filed 2013-03-18 | $3.15K 10-K · filed 2012-02-23 | |||||||||||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-14 | $74.00 derived: sum of 2 quarters · filed 2012-11-14 | $338.00 10-Q · filed 2012-11-14 | $602.00 derived: sum of 4 quarters · filed 2012-11-14 | $3.15K 10-Q · filed 2012-02-23 | |||||||||||
| 2011-06-30 | $74.00 10-Q · filed 2012-08-14 | $338.00 10-Q · filed 2012-08-14 | $602.00 derived: sum of 3 quarters · filed 2012-08-14 | $866.00 derived: sum of 4 quarters · filed 2012-08-14 | $3.15K 10-Q · filed 2012-02-23 | |||||||||||
| 2011-03-31 | $264.00 10-Q · filed 2012-05-10 | $528.00 derived: sum of 2 quarters · filed 2012-05-10 | $792.00 derived: sum of 3 quarters · filed 2012-05-10 | |||||||||||||
| 2010-12-31 | $264.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $528.00 derived: sum of 2 quarters · filed 2012-02-23 | $1.06K 10-K · filed 2012-02-23 | |||||||||||||
| 2010-09-30 | $264.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-23 | $792.00 10-Q · filed 2012-02-23 | ||||||||||||||
| 2010-06-30 | $528.00 10-Q · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |